Innovating Works

IMAGSA TECHNOLOGIES

Inactiva
UCARE: Uncovering the epigenetic signature of female specifiC biological networks and key driver genes of c... IMAGSA TECHNOLOGIES participó en un H2020: ERC-2019-COG Cardiovascular disease causes 51% of deaths in women and 42% of deaths in men in Europe. Women are contributing mostly to the worrying trend...
2020-03-16 - 2025-08-31 | Financiado
SPELITEC: Sequence sPecific ELImination of shiga Toxin E. Coli IMAGSA TECHNOLOGIES participó en un H2020: H2020-EIC-SMEInst-2018-2020 SPELITEC is the first treatment for Shiga toxin-producing E. coli (STEC) infections, which affects primary young children and can be fatal i...
2019-06-14 - 2022-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.